Back to 
Susquehanna International Group, LLP
Susquehanna International Group, LLP
SXTC
Showing 0 of 3 quarters
Position history for Susquehanna International Group, LLP's holdings in China SXT Pharmaceuticals, Inc.
No. Susquehanna International Group exited its SXTC (China SXT Pharmaceuticals) position in Q2 2022. Its Q1 2022 13F listed 336,469 shares worth $94,000. Susquehanna International Group first reported SXTC in Q4 2021 and held it in 2 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.